Putnam Investments LLC Iveric Bio, Inc. Transaction History

Putnam Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$26.24 - $39.63 $9.3 Million - $14 Million	-354,456 Reduced 63.55%	203,338 $8 Million
Q1 2023 May 22, 2023	BUY	$18.67 - $24.56 $3.38 Million - $4.44 Million	180,885 Added 47.99%	557,794 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $4 Million - $5.56 Million	232,209 Added 160.48%	376,909 $8.07 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $1.2 Million - $2.37 Million	127,698 Added 751.08%	144,700 $2.6 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $155,058 - $321,337	17,002 New	17,002 $164,000

Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $1.39 Million - $1.93 Million	-114,582 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $1.58 Million - $2.15 Million	114,582 New	114,582 $1.92 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.